+ Follow AMYLOID Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 1323788
[Title] => Study: Antidepressant may cut Alzheimer's protein
[Summary] => Research shows a common antidepressant may cut production of one of the chief suspects behind Alzheimer's, a new avenue in the hunt for drugs to prevent the devastating brain disease.
[DatePublished] => 2014-05-16 07:07:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[1] => Array
(
[ArticleID] => 920686
[Title] => Despite setbacks, Alzheimer’s tx pipeline is full
[Summary] => More than 60 drugs remain in the developmental pipeline for Alzheimer’s disease, although the past several years have seen numerous once-promising agents bite the dust.
[DatePublished] => 2013-03-17 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[2] => Array
(
[ArticleID] => 891424
[Title] => New imaging agent correlates amyloid with Alzheimer’s
[Summary] => Positron-emission tomography in combination with the radio labeled compound florbetapir F-18 detected beta-amyloid plaques with 93% sensitivity and 100% specificity in the brains of 35 elderly patients, most of whom had some form of dementia.
[DatePublished] => 2012-12-30 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[3] => Array
(
[ArticleID] => 610883
[Title] => Amyloid theory sputters for AD
[Summary] => The amyloid hypothesis isn’t dead, but it seems to be limping a bit in the race for an Alzheimer’s cure.
[DatePublished] => 2010-09-12 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[4] => Array
(
[ArticleID] => 498130
[Title] => Amyloid scans may aid Alzheimer's diagnosis
[Summary] => Radionuclide imaging products that reliably detect cerebral amyloid deposits would be clinically useful in ruling out a diagnosis of Alzheimer’s disease in patients with cognitive impairment, according to a Food and Drug administration advisory panel.
[DatePublished] => 2009-08-23 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
)
)
AMYLOID
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 1323788
[Title] => Study: Antidepressant may cut Alzheimer's protein
[Summary] => Research shows a common antidepressant may cut production of one of the chief suspects behind Alzheimer's, a new avenue in the hunt for drugs to prevent the devastating brain disease.
[DatePublished] => 2014-05-16 07:07:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[1] => Array
(
[ArticleID] => 920686
[Title] => Despite setbacks, Alzheimer’s tx pipeline is full
[Summary] => More than 60 drugs remain in the developmental pipeline for Alzheimer’s disease, although the past several years have seen numerous once-promising agents bite the dust.
[DatePublished] => 2013-03-17 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[2] => Array
(
[ArticleID] => 891424
[Title] => New imaging agent correlates amyloid with Alzheimer’s
[Summary] => Positron-emission tomography in combination with the radio labeled compound florbetapir F-18 detected beta-amyloid plaques with 93% sensitivity and 100% specificity in the brains of 35 elderly patients, most of whom had some form of dementia.
[DatePublished] => 2012-12-30 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[3] => Array
(
[ArticleID] => 610883
[Title] => Amyloid theory sputters for AD
[Summary] => The amyloid hypothesis isn’t dead, but it seems to be limping a bit in the race for an Alzheimer’s cure.
[DatePublished] => 2010-09-12 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[4] => Array
(
[ArticleID] => 498130
[Title] => Amyloid scans may aid Alzheimer's diagnosis
[Summary] => Radionuclide imaging products that reliably detect cerebral amyloid deposits would be clinically useful in ruling out a diagnosis of Alzheimer’s disease in patients with cognitive impairment, according to a Food and Drug administration advisory panel.
[DatePublished] => 2009-08-23 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
)
)
abtest
